
We find, analyze and isolate the most valuable cells with ease and speed. Sphere Bio | Cell Selection, Sorted.
Investors 1
Date | Name | Website |
06.03.2025 | Parkwalk A... | parkwalkad... |
Mentions in press and media 2
Date | Title | Description |
09.04.2025 | Sphere Bio expands APAC distribution network to strengthen presence in region | Operational scale-up accelerates global growth strategy to increase regional access and technical support Cambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis a... |
31.03.2025 | Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection | First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and... |